Corpus Intelligence IC Memo — INDIANA REGIONAL MEDICAL CENTER 2026-04-26 13:29 UTC
IC Memo — INDIANA REGIONAL MEDICAL CENTER
Investment Committee Memorandum | PA | 134 beds | Grade C | EBITDA uplift $14.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

INDIANA REGIONAL MEDICAL CENTER

CCN 390173 | INDIANA, PA | 134 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

INDIANA REGIONAL MEDICAL CENTER is a 134-bed suburban community hospital in INDIANA, PA with $189.7M in net patient revenue and a -3.2% operating margin. The hospital serves a payer mix of 1.1% Medicare, 1.2% Medicaid, and 97.7% commercial.

Thesis: Undervalued. Our ML models identify $14.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.2% to 4.2% (+736bps).

Net Revenue HCRIS$189.7M
Current EBITDA COMPUTED$-6.0M
Operating Margin COMPUTED-3.2%
Occupancy HCRIS46.4%
Revenue / Bed COMPUTED$1.4M
Net-to-Gross HCRIS29.6%
Distress Probability ML46.9%

2. Market Context & Competitive Position

225
PA Hospitals
-4.4%
State Median Margin
107
Comparable Hospitals

PA has 225 Medicare-certified hospitals with a median operating margin of -4.4%. The target's margin of -3.2% places it above the state median. Among 107 size-comparable peers (67-268 beds), the median margin is -7.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (67-268), prioritizing same-state peers. 107 hospitals in the comp set.

HospitalStateBedsRevenueMargin
INDIANA REGIONAL MEDICAL CENTE (Target)PA134$189.7M-3.2%
WESTERN PENNSYLVANIA HOSPITALPA255$776.4M11.1%
COMMUNITY MEDICAL CENTERPA266$474.1M3.1%
ROBERT PACKER HOSPITALPA252$471.8M-2.1%
WILLIAMSPORT HOSPITAL & MEDICAPA227$459.8M-8.4%
MOUNT NITTANY MEDICAL CENTERPA248$441.7M12.6%
MEMORIAL MEDICAL CENTERPA241$435.1M-21.2%
THE CHAMBERSBURG HOSPITALPA234$435.1M5.2%
ST LUKE HOSPITAL ANDERSON CAMPPA193$433.0M20.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.0M+210bp18mo
Cost to Collect4.5%2.5%$3.8M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.3M+122bp9mo
Clean Claim Rate88.0%96.0%$121K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.0M
Cost to Collect
$3.8M
Denial Rate Reduction
$3.8M
A/R Days Reduction
$2.3M
Clean Claim Rate
$121K
Total EBITDA Uplift$14.0M
Current EBITDA$-6.0M
+ RCM Uplift+$14.0M
Pro Forma EBITDA$8.0M
Current Margin-3.2%
Pro Forma Margin4.2%
WC Released (1x)$7.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-9.2M$100.0M0.00x-100.0%
Base (11x exit)10.0x11.0x$-9.2M$107.0M0.00x-100.0%
Bull Case9.0x11.0x$-8.3M$150.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-8.3M$161.3M0.00x-100.0%
Bear Case11.0x10.0x$-10.2M$33.2M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-10.2M$33.2M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 107 hospitals with 67-268 beds
  • Same-state prioritization (n=108)
  • Comp margins: P25=-18.5% / P50=-7.0% / P75=5.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.